Among 205 patients with ER-positive metastatic breast cancer (defined by DCC) who were followed for a median of 9 years, the percentage of ER positively immunostained tumor cell nuclei was positively associated with the cumulative probability of survival [27]. The gene discussed is ESR1; the disease is neoplasm.